Guizhou's Sanli Pharmaceutical completes IPO

Guizhou Sanli Pharmaceutical Co., Ltd. (603439.SH), an invested enterprise of Guiyang Gongtou Biopharmaceutical Fund, was listed on the Shanghai Stock Exchange on April 28, issuing 40.74 million ordinary shares at a price of 7.35 yuan ($1.03) per share.